1. Beachey EH and Seyer JM. (1986). Protective and nonprotective epitopes of chemically synthesized peptides of the NH2-terminal region of type 6 streptococcal M protein. J Immunol, 136:2287–2292.
2. Bessen D and Fischetti VA. (1988). Influence of intranasal immunization with synthetic peptides corresponding to conserved epitopes of M protein on mucosal colonization by group A streptococci. Infect Immun, 56:2666–2672.
3. Bisno AL. (2001). Acute pharyngitis. N Engl J Med, 344:205–211.
4. Bisno AL, Rubin FA, Cleary PP, and Dale JB. (2005). Prospects for a group A streptococcal vaccine: rationale, feasibility, and obstacles–report of a National Institute of Allergy and Infectious Diseases workshop. Clin Infect Dis, 41:1150–1156.
5. Bolken TC, Franke CA, Jones KF, Bell RH, Swanson RM, King DS, Fischetti VA, and Hruby DE. (2002). Analysis of factors affecting surface expression and immunogenicity of recombinant proteins expressed by gram-positive commensal vectors. Infect Immun, 70:2487–2491.